WallStreetZenWallStreetZen

NASDAQ: ONCT
Oncternal Therapeutics Inc Stock Forecast, Predictions & Price Target

Analyst price target for ONCT

Based on 3 analysts offering 12 month price targets for Oncternal Therapeutics Inc.
Min Forecast
$1.30+324.84%
Avg Forecast
$5.77+1,784.64%
Max Forecast
$9.00+2,841.18%

Should I buy or sell ONCT stock?

Based on 3 analysts offering ratings for Oncternal Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
Buy
2 analysts 66.67%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ONCT stock forecasts and price targets.

ONCT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 3%
3
Strong BuyMaintains$1.30+324.84%2023-04-04
Oppenheimer
Bottom 39%
39
BuyMaintains$9.00+2,841.18%2023-03-22
HC Wainwright & Co.
Bottom 3%
3
BuyReiterates$7.00+2,187.58%2023-03-14

1 of 1

Forecast return on equity

Is ONCT forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.96%

Forecast return on assets

Is ONCT forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

ONCT revenue growth forecast

How is ONCT forecast to perform vs Biotechnology companies and vs the US market?
Company
5.55%
Industry
40.04%
Market
8.43%
ONCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ONCT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ONCT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ONCT$0.31$5.77+1,784.64%Strong Buy
NHWK$0.69N/AN/A
MBRX$0.61$10.50+1,624.14%Strong Buy
HGEN$0.15$0.33+118.12%Sell
SQZ$0.60N/AN/A

Oncternal Therapeutics Stock Forecast FAQ

Is Oncternal Therapeutics Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: ONCT) stock is to Strong Buy ONCT stock.

Out of 3 analysts, 1 (33.33%) are recommending ONCT as a Strong Buy, 2 (66.67%) are recommending ONCT as a Buy, 0 (0%) are recommending ONCT as a Hold, 0 (0%) are recommending ONCT as a Sell, and 0 (0%) are recommending ONCT as a Strong Sell.

If you're new to stock investing, here's how to buy Oncternal Therapeutics stock.

What is ONCT's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ONCT) forecast ROE is N/A, which is considered weak.

What is ONCT's Price Target?

According to 3 Wall Street analysts that have issued a 1 year ONCT price target, the average ONCT price target is $5.77, with the highest ONCT stock price forecast at $9.00 and the lowest ONCT stock price forecast at $1.30.

On average, Wall Street analysts predict that Oncternal Therapeutics's share price could reach $5.77 by Apr 4, 2024. The average Oncternal Therapeutics stock price prediction forecasts a potential upside of 1,784.64% from the current ONCT share price of $0.31.

What is ONCT's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ONCT) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.